Vicebio
Updated: October 31, 2025
CEO - Emmanuel Hanon
Country: UK | Funding: $100M (+)
Website: https://vicebio.com/
Vicebio is committed to employing the Molecular Clamp Technology to create vaccines against next-generation respiratory viruses.
Website: https://vicebio.com/
Vicebio is committed to employing the Molecular Clamp Technology to create vaccines against next-generation respiratory viruses.
